Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
The FEBS Journal
|
April 1, 2015
STAT3 the oncogene - still eluding therapy?
Matthew S Wake, Christine J Watson
American Journal of Medical Genetics
|
July 12, 1996
Prevalence of fragile X syndrome
G Turner, T Webb, S Wake, et al.
Australian Dental Journal
|
April 1, 1976
Cigarette smoking and the microbial flora of the mouth
G Colman, D Beighton, A J Chalk, et al.
American Journal of Medical Genetics
|
July 12, 1996
Informed choice in fragile X syndrome and its effects on prevalence
H Robinson, S Wake, F Wright, et al.
Prenatal Diagnosis
|
June 30, 2007
An evaluation of a shared experience group for women and their support persons following prenatal diagnosis and termination for a fetal abnormality
L Gordon, A Thornton, S Lewis, et al.
Journal of Medical Genetics
|
January 1, 1988
The use of restriction fragment length polymorphisms in prenatal diagnosis of dihydropteridine reductase deficiency
H H Dahl, S Wake, R G Cotton, et al.
The Medical Journal of Australia
|
August 7, 1989
Analysis of DNA probes for the prenatal diagnosis of cystic fibrosis
P J Dry, S Wake, C F Robertson, et al.
American Journal of Medical Genetics
|
December 4, 1995
Dissemination of genetic risk information to relatives in the fragile X syndrome: guidelines for genetic counselors
A McConkie-Rosell, H Robinson, S Wake, et al.
Journal of Clinical Pathology
|
September 1, 1991
Comparison of cell culture with an amplified enzyme immunoassay for diagnosing genital herpes simplex infection
G Kudesia, A Van Hegan, S Wake, et al.
American Journal of Medical Genetics
|
July 15, 1994
Counselling risk figures for fragile X carrier females of varying band sizes for use in predicting the likelihood of retardation in their offspring
A M Turner, H Robinson, S Wake, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
The FEBS Journal
|
April 1, 2015
STAT3 the oncogene - still eluding therapy?
Matthew S Wake, Christine J Watson
American Journal of Medical Genetics
|
July 12, 1996
Prevalence of fragile X syndrome
G Turner, T Webb, S Wake, et al.
Australian Dental Journal
|
April 1, 1976
Cigarette smoking and the microbial flora of the mouth
G Colman, D Beighton, A J Chalk, et al.
American Journal of Medical Genetics
|
July 12, 1996
Informed choice in fragile X syndrome and its effects on prevalence
H Robinson, S Wake, F Wright, et al.
Prenatal Diagnosis
|
June 30, 2007
An evaluation of a shared experience group for women and their support persons following prenatal diagnosis and termination for a fetal abnormality
L Gordon, A Thornton, S Lewis, et al.
Journal of Medical Genetics
|
January 1, 1988
The use of restriction fragment length polymorphisms in prenatal diagnosis of dihydropteridine reductase deficiency
H H Dahl, S Wake, R G Cotton, et al.
The Medical Journal of Australia
|
August 7, 1989
Analysis of DNA probes for the prenatal diagnosis of cystic fibrosis
P J Dry, S Wake, C F Robertson, et al.
American Journal of Medical Genetics
|
December 4, 1995
Dissemination of genetic risk information to relatives in the fragile X syndrome: guidelines for genetic counselors
A McConkie-Rosell, H Robinson, S Wake, et al.
Journal of Clinical Pathology
|
September 1, 1991
Comparison of cell culture with an amplified enzyme immunoassay for diagnosing genital herpes simplex infection
G Kudesia, A Van Hegan, S Wake, et al.
American Journal of Medical Genetics
|
July 15, 1994
Counselling risk figures for fragile X carrier females of varying band sizes for use in predicting the likelihood of retardation in their offspring
A M Turner, H Robinson, S Wake, et al.
Page
of 2